Back to top

FDA posts approval of Edwards left atrial appendage system

The FDA posted 510(k) Premarket Notification approval of Edwards Lifesciences’ (EW) Ecliptis Left Atrial Appendage Exclusion System. Shares of Atri...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

AtriCure, Inc. (ATRC)

Edwards Lifesciences Corporation (EW)

iShares MSCI Switzerland ETF (EWL)